Business Description
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.
Business History
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): -1.66
Total Equity: $61.05M
Shares: 41,727,983
Total Debt: $36.08M
Cash: $40.55M
EBITDA: -$62.65M
Total Debt: $36.08M
Cash: $40.55M
Revenue: $35.26M
Shares: 41,727,983
Revenue: $35.26M
Revenue: $35.26M
Revenue: $35.26M
Total Equity: $61.05M
Tax Rate: 0.0%
Equity: $61.05M
Total Debt: $36.08M
Cash: $40.55M
Current Liabilities: $24.35M
Long-Term Debt: $35.59M
Total Debt: $36.08M
Total Equity: $61.05M
Shares: 41,727,983
Shares: 41,727,983
CapEx: -$1.12M
Shares: 41,727,983
Stock Price: $5.72
Net Income: -$69.11M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 25, 2026 8:22pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $13.7M | $16.4M | $22.4M | $22.5M | $35.3M |
| Cost of Revenue | $14.5M | $13.7M | $19.3M | $21.9M | $19.5M |
| Gross Profit | $-811,000 | $2.7M | $3.1M | $533,000 | $15.8M |
| Operating Expenses | $56.4M | $71.4M | $78.7M | $75.4M | $84.1M |
| Operating Income | -$57.2M | -$68.6M | -$75.6M | -$74.8M | -$68.3M |
| Net Income | -$302.5M | $142.1M | -$60.4M | -$78.6M | -$69.1M |
| EBITDA | -$284.5M | $161.8M | -$48.0M | -$68.7M | -$62.7M |
| EPS | $-14.40 | $6.07 | $-2.20 | $-2.50 | $-1.66 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 25, 2026 8:22pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $33.5M | $35.8M | $75.7M | $74.6M | $40.5M |
| Total Current Assets | $144.4M | $161.2M | $130.0M | $91.4M | $117.5M |
| Total Assets | $198.9M | $177.7M | $138.2M | $100.4M | $126.3M |
| Current Liabilities | $18.4M | $31.5M | $17.3M | $38.8M | $24.3M |
| Long-Term Debt | $59.8M | $56.4M | $41.2M | $34.7M | $35.6M |
| Total Liabilities | $384.5M | $180.2M | $102.4M | $117.0M | $65.2M |
| Total Equity | -$185.5M | -$2.6M | $35.8M | -$16.6M | $61.0M |
| Retained Earnings | -$951.0M | -$808.9M | -$869.3M | -$947.9M | -$1.0B |
Cash Flow (Annual)
Last updated: Jun 25, 2026 8:22pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$56.1M | -$66.3M | -$70.2M | -$60.5M | -$59.1M |
| Capital Expenditure | $-210,000 | $-312,000 | $-350,000 | -$2.2M | -$1.1M |
| Free Cash Flow | -$56.3M | -$66.6M | -$70.5M | -$62.7M | -$60.2M |
| Acquisitions (net) | $210,000 | -$27.2M | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $15.3M | $2.3M | $39.9M | $-797,000 | -$34.4M |
Analyst Estimates (Annual)
Last updated: Jun 26, 2026 10:43pm (10h ago)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$97.9M $93.1M – $104.6M
|
$124.7M $119.4M – $130.1M
|
$171.4M $161.8M – $192.3M
|
$232.2M $219.3M – $260.6M
|
| EBITDA |
-$58.7M -$62.8M – -$55.9M
|
-$74.8M -$78.0M – -$71.6M
|
-$102.8M -$115.4M – -$97.1M
|
-$139.3M -$156.4M – -$131.6M
|
| Net Income |
-$97.1M -$113.9M – -$80.2M
|
-$67.3M -$86.7M – -$48.0M
|
-$40.2M -$46.6M – -$37.3M
|
-$8.6M -$10.0M – -$8.0M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 25, 2026 8:22pm (1d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +19.8% | +36.6% | +0.4% | +56.9% |
| Gross Profit Growth | +436.1% | +13.4% | -82.8% | +2,857.4% |
| Operating Income Growth | -20.0% | -10.2% | +1.0% | +8.7% |
| Net Income Growth | +147.0% | -142.5% | -30.2% | +12.1% |
| EBITDA Growth | +156.9% | -129.7% | -43.1% | +8.8% |
Narrative Economics
market-narrative step).